Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients

Clinical trial NCT00470665 · COMPLETED

Trial details

NCT number: NCT00470665
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Renal Allograft Recipients

Start date: 2002-08-01
Enrollment: 460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.